NUS has been the subject of several other research reports. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a research note on Tuesday, February 12th. Citigroup set a $86.00 price target on Nu Skin Enterprises and gave the company a “buy” rating in a research note on Friday, February 15th. Bank of America reissued an “underperform” rating and issued a $65.00 price target on shares of Nu Skin Enterprises in a research note on Friday, April 12th. Pivotal Research reissued a “buy” rating and issued a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, March 13th. Finally, TheStreet cut Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Thursday, February 14th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $73.75.
Shares of NYSE NUS opened at $51.11 on Friday. The company has a market capitalization of $2.97 billion, a P/E ratio of 14.52, a PEG ratio of 1.23 and a beta of 0.67. Nu Skin Enterprises has a 52 week low of $44.36 and a 52 week high of $88.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.86 and a quick ratio of 1.10.
A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. boosted its position in Nu Skin Enterprises by 19.5% during the first quarter. BlackRock Inc. now owns 7,498,023 shares of the company’s stock worth $358,856,000 after purchasing an additional 1,224,725 shares during the period. Wellington Management Group LLP boosted its position in Nu Skin Enterprises by 2.0% during the first quarter. Wellington Management Group LLP now owns 2,024,524 shares of the company’s stock worth $96,894,000 after purchasing an additional 40,465 shares during the period. Renaissance Technologies LLC boosted its position in Nu Skin Enterprises by 79.2% during the first quarter. Renaissance Technologies LLC now owns 1,253,411 shares of the company’s stock worth $59,988,000 after purchasing an additional 554,011 shares during the period. Dimensional Fund Advisors LP boosted its position in Nu Skin Enterprises by 4.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,182,814 shares of the company’s stock worth $56,610,000 after purchasing an additional 50,496 shares during the period. Finally, Norges Bank bought a new stake in Nu Skin Enterprises during the fourth quarter worth approximately $56,136,000. 74.80% of the stock is owned by hedge funds and other institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Read More: How to Invest in a Bull Market
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.